IP Library Granted Patent US 7,527,943
Granted Patent B2
US 7,527,943 · App. 10/563,656 · Granted May 5, 2009

Compositions of orthogonal glutamyl-tRNA and aminoacyl-tRNA synthetase pairs and uses thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,527,943
App. No.
10/563,656
Granted
May 5, 2009
Kind
B2
Abstract

Compositions and methods of producing components of protein biosynthetic machinery that include glutamyl orthogonal tRNAs, glutamyl orthogonal aminoacyl-tRNA synthetases, and orthogonal pairs of glutamyl tRNAs/synthetases are provided. Methods for identifying these orthogonal pairs are also provided along with methods of producing proteins using these orthogonal pairs.

Claims (23)

1. A composition comprising an orthogonal glutamyl-tRNA (glutamyl O-tRNA), wherein the glutamyl O-tRNA comprises the polynucleotide sequence of SEQ ID NO.: 67 or is transcribed from a complementary polynucleotide sequence thereof;

and wherein the glutamyl O-tRNA suppresses in the presence of tRNA synthetase (RS) selected from the group consisting of: an Archaeoglobus fulgidus synthetase, a Methanosarcina mazei synthetase, a Methanobacterium thermoautotrophicum synthetase, and a Pyrococcus horikoshii synthetase.

2. The composition of claim 1 , further comprising a polynucleotide comprising a selector codon that is an amber codon.

3. The composition of claim 1 , wherein the -tRNA synthetase preferentially aminoacylates the glutamyl O-tRNA with a selected amino acid.

4. The composition of claim 3 , wherein a suppression efficiency of the tRNA synthetase and the glutamyl O-tRNA together is 4 to 5-fold greater than a suppression efficiency of the glutamyl O-tRNA in the absence of the glutamyl-tRNA synthetase.

5. The composition of claim 3 , wherein the tRNA synthetase comprises an amino acid sequence comprising any one of SEQ ID NO.: 69 (AfRS), SEQ ID NO.: 73 (MmRS), SEQ ID NO.: 75 (MtRS), or SEQ ID NO.: 77 (PhRS).

6. The composition of claim 1 , comprising a cell.

7. The composition of claim 6 , wherein the cell is an E. coli cell.

8. The composition of claim 1 , comprising a translation system.

9. A cell comprising a translation system, wherein the translation system comprises:

an orthogonal glutamyl-tRNA (glutamyl O-tRNA) comprising the polynucleotide sequence of SEQ ID NO.: 67 or is transcribed from a complementary polynucleotide sequence thereof;

a glutamyl-tRNA synthetase derived from a tRNA synthetase (RS) selected from the group consisting of: SEQ ID NO.: 69 (AfRS), SEQ ID NO.: 73 (MmRS), SEQ ID NO.: 75 (MtRS) and SEQ ID NO.: 77 (PhRS); and,

a first selected amino acid;

wherein the glutamyl O-tRNA recognizes a first selector codon, and the tRNA synthetase preferentially aminoacylates the glutamyl O-tRNA with the first selected amino acid.

10. The cell of claim 9 , wherein the cell further comprises an additional different O-tRNA/tRNA synthetase pair and a second selected amino acid, wherein the additional O-tRNA recognizes a second selector codon and the additional tRNA synthetase preferentially aminoacylates the additional O-tRNA with the second selected amino acid.

11. The cell of claim 9 , wherein the cell is a non-eukaryotic cell.

12. The cell of claim 11 , wherein the non-eukaryotic cell is an E. coli cell.

13. The cell of claim 9 , further comprising a nucleic acid that comprises a polynucleotide that translates into a polypeptide of interest, wherein the polynucleotide comprises a selector codon that is recognized by the glutamyl O-tRNA.

14. An E. coli cell, comprising:

an orthogonal glutamyl tRNA (glutamyl O-tRNA), wherein the glutamyl O-tRNA comprises the polynucleotide sequence of SEQ ID NO.: 67 or is transcribed from a complementary polynucleotide sequence thereof;

a glutamyl-tRNA synthetase, wherein the glutamyl-tRNA synthetase preferentially aminoacylates the glutamyl O-tRNA with a selected amino acid;

the selected amino acid; and,

a nucleic acid that comprises a polynucleotide that encodes a polypeptide of interest, wherein the polynucleotide comprises the selector codon that is recognized by the glutamyl O-tRNA, and wherein the glutamyl-tRNA synthetase comprises a glutamyl-RS selected from the group consisting of: an Archaeoglobus fulgidus (Af) synthetase, a Methanosarcina mazei (Mm) synthetase, a Methanobacterium thermoautotrophicum (Mt) synthetase, and a Pyrococcus horikoshii (Ph) synthetase.

Assignments (3)
EXECUTIVE ORDER 9424, CONFIRMATORY LICENSE Recorded Nov 14, 2008
From: SCRIPPS RESEARCH INSTITUTE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021837/0532 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 22, 2006
From: ANDERSON, J. CHRISTOPHER; SCHULTZ, PETER G.; SANTORO, STEPHEN
To: SCRIPPS RESEARCH INSTITUTE, THE
Reel/Frame 017838/0079 →
CONFIRMATORY LICENSE Recorded Apr 27, 2006
From: SCRIPPS RESEARCH INSTITUTE, THE
To: ENGERY, UNITED STATES DEPARTMENT OF
Reel/Frame 017861/0469 →